About US
Contact us
-
GSK unloading drinks brands to Japan's Suntory for $2.1BGlaxoSmithKline ($GSK) is slimming down again, this time with a long-anticipated deal to sell off two of its drinks brands. What was not anticipated was the price--£1.35 billion, or $2.11 billio2013/9/10
-
Celgene's Abraxane approved for first-line treatment of pancreatic cancerThe FDA today approved Celgene'sAbraxaneforpancreatic cancer, an approval that provides some hope for extending the lives of patients with the aggressive cancer. It should also significantly extend th2013/9/9
-
Mallinckrodt tamper-resistant drug performs well for bunion patientsMallinckrodt ($MNK) has released good-news data from a Phase III study of an experimental pain drug for use by patients after bunion surgery. In June, the Dublin, Ireland-based drugmaker submitted a n2013/9/9
-
Merck poised for expansion of Zostavax shingles vax as demand growsAnalysts predicted Merck's ($MRK)shinglesvaccineZostavaxwould be a blockbuster when it was first released in 2006. But Merck quickly ran into manufacturing and supply issues, putting a damper on sales2013/9/6
-
Sanofi bets on safer aspirin combos with $35M Pozen dealSanofi ($SNY) is handing over a $15 million upfront payment along with promises of $20 million in precommercialization milestones to partner with Chapel Hill, NC-based Pozen ($POZN) on a pair of new-a2013/9/6
-
GlaxoSmithKline near $1.6B drinks-brands sale to Japan's SuntoryGlaxoSmithKline ($GSK) may be on the verge of bidding goodbye to two of its drink brands.Japan's Suntory Beverage & Food is in advanced talks to buy Lucozade and Ribena, the brands GSK put up for2013/9/6
-
The 2nd China-ASEAN Drug Safety Summit held in NanningThe 2nd China-ASEAN Drug Safety Summit, jointly sponsored by China Food and Drug Administration and People's Government of Guangxi Zhuang Autonomous Region, was held in Nanning China on September 3-4,2013/9/5
-
China talks about massive fines against GSKGSK China employees point fingers at former China head Mark Reilly It's never good when authorities talk openly of imposing "astronomical" fines on a drugmaker. But China officials have suggested tha2013/9/4
-
Eli Lilly's Alimta gains may cause Princeton painEli Lilly's success with Alimta has been a boon for Princeton University, which holds a key patent on the drug compound. But because of the university's $524 million in licensing income from the cance2013/9/4
-
CFDA Vice Minister Yin Li meets Iranian Ambassador to ChinaOn August 29, 2013, Yin Li, Vice Minister of China Food and Drug Administration (CFDA), met with the delegation led by Mr. Mahdi Safari, Iranian Ambassador to China. Both sides exchanged opinions on b2013/9/3